A significant breakthrough in cancer investigation is emerging with the use of mini-antibodies to reactivate dysfunctional p53. This vital cancer suppressor protein is frequently inactivated in various types of cancer, https://rotatesites.com/story23530498/mini-antibodies-reactivate-tumor-suppressor-p53-a-new-hope-for-malignant-therapy